Cargando…
Critical review of cancer risk associated with angiotensin receptor blocker therapy
The role of drugs in new cancer occurrence and cancer-related death is a major concern. Recently, a meta-analysis raised the possibility that angiotensin receptor blockers (ARBs) might have an adverse effect on patients. This generated a significant debate until the publication of two further meta-a...
Autores principales: | Wuerzner, Grégoire, Burnier, Michel, Waeber, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253767/ https://www.ncbi.nlm.nih.gov/pubmed/22241948 http://dx.doi.org/10.2147/VHRM.S13552 |
Ejemplares similares
-
Salt, blood pressure and cardiovascular risk: what is the most adequate preventive strategy? A Swiss perspective
por: Burnier, Michel, et al.
Publicado: (2015) -
New Aspects in the Management of Hypertension in Patients with Chronic Kidney Disease not on Renal Replacement Therapy
por: Damianaki, Aikaterini, et al.
Publicado: (2021) -
Hypertension and Drug Adherence in the Elderly
por: Burnier, Michel, et al.
Publicado: (2020) -
How Do I Manage Hypertension in Patients with Advanced Chronic Kidney Disease Not on Dialysis? Perspectives from Clinical Practice
por: Polychronopoulou, Erietta, et al.
Publicado: (2021) -
Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
por: Lee, Hyun Woong
Publicado: (2014)